AIOM | Associazione Italiana di Oncologia Medica

What AIOM | Associazione Italiana di Oncologia Medica does

AIOM (Associazione Italiana di Oncologia Medica) is the leading professional medical association for medical oncologists in Italy, founded on November 7, 1973, in Milan, with over 2,500 members across the country. The association operates as a unified platform for Italian medical oncology, organized through 19 regional sections covering all Italian regions, a 12-member National Directive Council (mandate 2025-2027), three working groups (AIOM Giovani for young oncologists under 40, AIOM Nursing, AIOM CRC for clinical research coordinators), and two wholly-owned subsidiaries: Fondazione AIOM (established 2005 for independent clinical research) and AIOM Servizi srl (event management). AIOM generates revenue through three streams: annual membership dues from oncologists, oncology nurses, and clinical research coordinators; fees from its national congress (rotating among Milan, Rome, and Naples since 2009) and regional educational events; and corporate sponsorships from pharmaceutical companies for guidelines and educational activities.

The association's core products are its SIGN/GRADE-methodology clinical guidelines (Linee Guida AIOM) covering 35+ oncology topics with annual updates, published on the Italian National Guidelines System (SNLG); the Studi Clinici clinical trials platform (studiclinici.aiom.it); recommendations and position papers co-developed with partner societies (SIRM, SIE, SIAPEC, AISF, and others); the annual cancer statistics report "I Numeri del Cancro in Italia"; and the Annuario dell'Oncologia Italiana (co-published with FICOG). Supporting digital infrastructure includes the member portal (soci.aiom.it), the NUTRIVITA nutritional guidance app, and an active five-channel social media presence. AIOM holds ISO 9001:2015 quality certification (Certificate No. 9122 through IMQ, continuously since 2000), is a member of UICC and FISM, and was the first scientific society to register with the Italian Ministry of Health's national registry of scientific societies (October 22, 2017) under Law 24/2017. The association's go-to-market is community-led: it serves practicing oncologists through guidelines, continuing medical education (ECM) credits, congresses, clinical trials information, and a 19-section regional networking backbone, with secondary audiences of oncology nurses, clinical research coordinators, and patient associations through the PRO4all initiative.

Name

AIOM | Associazione Italiana di Oncologia Medica

Legal name

Associazione Italiana di Oncologia Medica

Website

https://aiom.it

Company type

Private

Founded year

1973

Operating status

Operating

Headcount range

11–50 employees

Short description

AIOM is the leading Italian professional medical association for medical oncologists, serving 2,500+ members through clinical guidelines, an annual national congress, a clinical trials platform, and 19 regional sections, with two subsidiaries (Fondazione AIOM, AIOM Servizi srl) supporting research and events.

Ownership category

akta.pro rank

Headquarters

HQ city

Milano, Lombardia

HQ country

Italy

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D

Revenue model

1. Membership Dues: Annual membership fees paid by oncologists, oncology nurses, clinical research coordinators, and other members. Reduced rates are available for residents, associate members, and dual ESMO/AIOM members. Dues are payable by the end of June each year.
2. Congress and Event Fees: Revenue from national congresses, regional events, educational courses, and other scientific meetings organized by AIOM. Events are organized through AIOM Servizi srl, a wholly-owned subsidiary.
3. Corporate Sponsorships: Pharmaceutical company sponsorships and support for educational events, guidelines development, and association activities. AIOM maintains strict conflict of interest policies requiring disclosure from all participants.

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels9 records

Core offering

AIOM is a non-profit professional medical association that develops and publishes evidence-based clinical oncology guidelines (Linee Guida AIOM), provides continuing medical education (ECM credits), organizes national and regional congresses, and maintains a clinical trials database for Italian oncologists. The association serves over 2,500 members through 19 regional sections, multiple working groups (AIOM Giovani, AIOM Nursing, AIOM CRC), and operates through two wholly-owned subsidiaries (Fondazione AIOM for independent research and AIOM Servizi srl for event management).

Product overview

AIOM is a professional medical association operating as a unified platform for Italian medical oncology. Its core offerings include clinical guidelines (Linee Guida AIOM) covering over 40 tumor types and care aspects, a clinical trials database (Studi Clinici), and an annual national congress. The organization publishes recommendations, position papers, and the Annuario dell'Oncologia Italiana. Supporting services include member portal (Area Soci), multiple working groups (Giovani, Nursing, CRC), and two subsidiaries: Fondazione AIOM for research promotion and AIOM Servizi srl for event management. The association also coordinates 19 regional sections across Italy.

Differentiator

Problem solved

Functional benefit

Products and services

• Linee Guida AIOM (AIOM Clinical Guidelines) Comprehensive clinical guidelines on oncology topics covering tumor types, treatment protocols, supportive care, and survivorship, developed using SIGN/GRADE methodology with annual updates and publication on the National Guidelines System (SNLG) platform. Targeted at Italian medical oncologists and healthcare professionals.
• Raccomandazioni & Position Paper Recommendations and position papers on specific oncology topics including testing guidelines, treatment approaches, and clinical practice statements. Targeted at Italian oncologists and multidisciplinary healthcare teams.
• Studi Clinici (Clinical Trials Platform) Online platform (studiclinici.aiom.it) listing ongoing clinical trials in Italy, accessible to oncologists and patients for trial enrollment and research visibility.
• Congresso Nazionale AIOM (National Congress) Annual national congress bringing together oncology professionals for scientific exchange, education, guideline presentations, and networking. The congress rotates among Milan, Rome, and Naples.
• Working Group AIOM (Giovani, Nursing, CRC) Specialized working groups focusing on young oncologists (AIOM Giovani), nursing professionals (AIOM Nursing), and clinical research coordinators (AIOM CRC). Targeted at sub-segments of the Italian oncology community.
• Annuario dell'Oncologia Italiana AIOM-FICOG Annual publication documenting the state of Italian oncology including research output, center performance, and cancer statistics, co-published with FICOG.
• I Numeri del Cancro in Italia Cancer statistics report providing epidemiological data on cancer incidence, prevalence, and outcomes in Italy for healthcare professionals, media, and policymakers.
• Area Soci (Member Portal) Reserved online area (soci.aiom.it) for AIOM members providing access to exclusive content, voting in elections, and member services.
• Fondazione AIOM Non-profit foundation established by AIOM in 2005 to promote independent clinical research in cancer prevention, diagnosis, and treatment, and to support patient information initiatives.
• AIOM Servizi srl Wholly-owned service company managing events and initiatives in the biomedical sector, particularly oncology, including the National Congress and regional events.

Quantifiable outcome

• AIOM's guidelines are developed using SIGN/GRADE methodology with annual updates, multidisciplinary panels, and conflict of interest declarations, meeting the requirements of Law 24/2017.
• +1 more outcomes

Named customers4 records

Segments5 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

19 partnerships are on record, tiered core and minor.

• AIFA (Agenzia Italiana del Farmaco)coreStrategic or Co-development Partner · 7 May 2026AIOM and AIFA strengthened their collaboration on monitoring registries for oncology, establishing a joint working table to enhance real-world data utilization in oncology. This partnership leverages AIFA's regulatory authority with AIOM's clinical expertise to improve registry-based evidence generation.
• Fondazione AIOMcoreStrategic or Co-development PartnerFondazione AIOM was established by AIOM in 2005 as a non-profit foundation with the purpose of promoting independent clinical research in cancer prevention, diagnosis, and treatment; serving as a link between oncologists and patients; informing patients and citizens; and engaging with patient volunteer associations.
• UICC (Union for International Cancer Control)coreStrategic or Co-development PartnerAIOM is a member of the Union for International Cancer Control, the leading international non-governmental organization dedicated to cancer control and prevention.
• FISM (Federazione delle Società Medico-Scientifiche Italiane)coreStrategic or Co-development PartnerAIOM is a member of the Federation of Italian Medical-Scientific Societies, which represents and coordinates medical scientific societies in Italy.
• SIRM (Società Italiana di Radiologia Medica e Interventistica)coreStrategic or Co-development PartnerAIOM and SIRM jointly publish recommendations on radiology practices for cancer patients, including recommendations for computed tomography (CT) requests and radiological reporting for oncology patients (RBPCA SIRM-AIOM).
• SIE (Società Italiana di Ematologia)coreStrategic or Co-development PartnerAIOM and SIE co-publish inter-society guidelines, including the guidelines for the management of patients with classical Hodgkin lymphoma (Linfoma di Hodgkin classico).
• FICOG (Federazione Italiana di Oncologia Chirurgica)coreStrategic or Co-development PartnerAIOM and FICOG jointly publish the Annuario dell'Oncologia Italiana (Yearbook of Italian Oncology), providing comprehensive data on Italian oncology practice.
• AISF (Associazione Italiana per lo Studio del Fegato)minorStrategic or Co-development PartnerAIOM and AISF jointly published inter-society guidelines for the multidisciplinary management of patients with hepatocellular carcinoma (epatocarcinoma).
• SINPE (Società Italiana di Nutrizione Artificiale e Metabolismo)minorStrategic or Co-development PartnerAIOM and SINPE jointly publish updated recommendations for nutritional support in cancer patients (Raccomandazioni pratiche per il supporto nutrizionale nel paziente oncologico).
• CIPOMO (Collegio Italiano dei Primari di Oncologia Medica)minorStrategic or Co-development PartnerAIOM collaborated with CIPOMO and COMU on COVID-19 vaccination recommendations for cancer patients, providing unified guidance during the pandemic.
• COMU (Centro di Oncologia Medica)minorStrategic or Co-development PartnerAIOM collaborated with CIPOMO and COMU on COVID-19 vaccination recommendations for cancer patients, providing unified guidance during the pandemic.
• SIF (Società Italiana di Farmacologia)minorStrategic or Co-development PartnerAIOM and SIF jointly publish recommendations on pharmacogenetic testing (Raccomandazioni per analisi farmacogenetiche) for oncology patients.
• SIGU (Società Italiana di Genetica Umana)minorStrategic or Co-development PartnerAIOM and SIGU jointly published a document on genetic counseling and genetic testing in oncology, addressing critical issues and proposals.
• SIAPEC (Società Italiana di Anatomia Patologica e Citologia)minorStrategic or Co-development PartnerAIOM and SIAPEC jointly publish recommendations for the evaluation of PD-L1 in cancer patients (Raccomandazioni AIOM-SIAPEC per la valutazione del PD-L1).
• SIGO (Società Italiana di Ginecologia e Ostetricia)minorStrategic or Co-development PartnerAIOM and SIGO jointly publish recommendations on oncofertility (fertilità in oncologia) for cancer patients of reproductive age.
• FAVO (Federazione Italiana delle Associazioni di Volontariato in Oncologia)minorStrategic or Co-development PartnerAIOM references FAVO's annual reports on the state of oncology care in Italy and collaborates on patient advocacy initiatives.
• SIRM (Società Italiana di Radiologia Medica e Interventistica) / SIN (Società Italiana di Nefrologia)minorStrategic or Co-development PartnerAIOM co-published 2020 inter-society recommendations with SIRM and SIN on radiology and nephrology topics relevant to oncology patients.
• SIAARTI (Società Italiana di Anestesia e Rianimazione)minorStrategic or Co-development PartnerAIOM and SIAARTI jointly published recommendations on appropriateness in the shared care pathway for adult cancer patients in hospital settings in complex clinical situations.
• ESMO (European Society for Medical Oncology)minorStrategic or Co-development PartnerAIOM offers reduced membership fees for members who are simultaneously enrolled in ESMO, and collaborates on educational activities including the ASCO-AIOM Clinical Research Course.

Scale indicators5 records

Recent moves8 records

Expansion highlights6 records

Direct peers

• European Society for Medical Oncology (ESMO): ESMO is the European medical oncology society with ~40,000 members, publishing clinical guidelines and running the annual ESMO Congress. AIOM explicitly collaborates with ESMO on dual memberships and joint courses, making ESMO the most direct functional peer.
• European Society for Radiotherapy & Oncology (ESTRO): ESTRO is the European multidisciplinary society for radiotherapy and oncology professionals, publishing clinical guidelines and educational resources. AIOM's joint work with SIRM (Italian radiology) on radiology recommendations parallels ESTRO's cross-disciplinary guideline approach.

Emerging players

• International Society of Geriatric Oncology (SIOG): SIOG is an international society dedicated to oncology in older adults, with guidelines, an annual meeting, and working groups. AIOM's active AIOM Anziani (oncology of the elderly) working group positions SIOG as a thematic peer addressing overlapping clinical content.

Broad incumbents

• Society of Surgical Oncology (SSO): SSO is a US-based broader oncology society covering surgical oncology with guidelines, meetings, and member education. It is comparable to AIOM as a specialty oncology professional society with strong guideline and education portfolios.
• American Society of Clinical Oncology (ASCO): ASCO is the largest global oncology society, publishing authoritative guidelines, running a massive annual meeting, and offering CME and quality programs. AIOM runs the ASCO-AIOM Clinical Research Course, illustrating ASCO's role as the global incumbent AIOM mirrors at the national level.

Others

• Federazione Italiana delle Associazioni di Volontariato in Oncologia (FAVO): FAVO is the Italian federation of oncology patient volunteer associations, collaborating with AIOM on patient advocacy and referenced in AIOM's cancer statistics work. It is an Italian ecosystem peer in the same oncology advocacy space.

Regional players

• Sociedad Española de Oncología Médica (SEOM): SEOM is the Spanish national medical oncology association, publishing clinical guidelines and representing oncologists in Spain. As a fellow ESMO member society serving a comparable healthcare system, SEOM is a direct regional peer to AIOM.
• Deutsche Gesellschaft für Hämatologie und Medizinische Onkologie (DGHO): DGHO is the German hematology and medical oncology society, publishing guidelines (Onkopedia) and running the DGHO annual meeting. It is the closest functional analog to AIOM in another major European healthcare market.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat6 records

Key risks4 records

Key highlights7 records

Customer concentration

• Xtwitter.com/aiomtweet
• YouTubeyoutube.com/channel/UC_2eo0YGzg6FvI6M2UL4Xeg
• Facebookfacebook.com/AIOM-1486602591666879
• LinkedInlinkedin.com/company/associazioneitalianaoncologiamedica
• Instagraminstagram.com/aiomoncologiaitaliana

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles12 records

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about AIOM | Associazione Italiana di Oncologia Medica